Lupin and TB Alliance Pact Strengthens Pipeline in Neglected Disease Segment
Hyderabad/Mumbai, Feb 2 (TNT): Lupin Limited on Monday announced it has entered into a strategic collaboration with TB Alliance to advance and commercialise Telacebec, an investigational therapy targeting tuberculosis (TB) and other mycobacterial diseases, marking a significant business move in the global anti-infectives space. The […….]
